Biggest diabetes medicine manufacturer, Lilly, ends operation in Pakistan due to rigid policies
Eli Lilly Pakistan (Private) Limited manufactures Humalog medical insulin, which is used to treat diabetes
Lilly, one of the biggest manufacturers of diabetes medicine in the world, has decided to end operations in Pakistan.
Eli Lilly Pakistan (Private) Limited manufactures Humalog medical insulin, which is used to treat diabetes. However, it has decided to put a stop on its operations at a time when the industry is already reeling from the increasing medical costs.
Another sad day for Pakistan’s Pharma Industry.
Lilly has closed its promotional activities in Pakistan 😭 pic.twitter.com/alOtXHfKo1
— Ahsan Awan (@Pharmacist_awan) November 11, 2022
The reason behind the closure has been rigid policies put in place by authorities. Top management at Lilly’s felt that multinational companies cannot compromise on standards, hence, the only plausible solution was to leave Pakistan altogether. The management is of the view that the government is not concerned with quality, efficacy and safety, and becaues of political reasons, the primary focus is on the price.
Lilly to end operaitons in Pakistan
In an official letter, it was stated that the US-based company would end its promotional efforts on 9th November, but the availability of the product would remain. To help patients who are using the products, Lilly will serve its products in Pakistan through its distributors AGCL.
The company letter added that hospitals can also continue to place orders for Lilly products with their current distributors. Exective Director of the Pharma Bureau, Ayesha Tammy Haq remarked that it is sad to see the exit of the research-based pharma company from Pakistan. She added that the first wave of mass exits was over 10 years ago, and this current wave is similar.
The director further added that currently, inflation is running at 30% and the rupee has dropped against the dollar. This has caused companies to request the government for an across-the-board price adjustment, which has not been considered yet. Furthermore, this has made it tough for any company to operate at a loss, and has led large-scale companies to make their exit from Pakistan.
What are your views on this? Share in the comments bar below.